• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Spectrum Pharmaceuticals

Spectrum Pharmaceuticals Announces New Employment Inducement Grant for Commercial Staff
January 26, 2023
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals Announces New Employment Inducement Grants for Commercial Staff
December 05, 2022
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals Provides Update on Poziotinib Following FDA Oncologic Drugs Advisory Committee Meeting
September 22, 2022
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update
July 29, 2022
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals to Report First Quarter 2022 Financial Results and Provide Corporate Update
May 06, 2022
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals Appoints Brittany K. Bradrick to Board of Directors
May 05, 2022
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals Announces Acceptance of New Drug Application Filing for Poziotinib
February 11, 2022
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals to Participate in B. Riley Securities 2022 Virtual Oncology Conference
January 20, 2022
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals Announces Strategic Restructuring
January 05, 2022
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib
December 06, 2021
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals to Participate in JMP Securities Hematology and Oncology Summit
November 30, 2021
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals to Participate in 2021 Jefferies London Healthcare Conference
November 11, 2021
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals to Report Third Quarter 2021 Financial Results and Provide Corporate Update
November 03, 2021
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals to Participate in 2021 Cantor Virtual Global Healthcare Conference
September 22, 2021
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals Announces Late-Breaking Oral Presentation of Data for Poziotinib in First-Line NSCLC Patients with HER2 Exon 20 Mutations at the Upcoming ESMO Congress 2021
September 13, 2021
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for ROLONTIS® (eflapegrastim)
August 06, 2021
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals to Report Second Quarter 2021 Financial Results and Provide Corporate Update
August 05, 2021
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals Presents Poziotinib Data in Patients with Brain Metastases from the ZENITH20 Clinical Trial at 2021 ASCO Annual Meeting
June 04, 2021
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals Announces That the ROLONTIS® (eflapegrastim) Pre-Approval Inspection Has Been Initiated
June 01, 2021
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals to Present Data for Poziotinib in Patients with Brain Metastases at the Upcoming 2021 ASCO Annual Meeting
May 28, 2021
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals to Participate in Two Upcoming Investor Conferences in June
May 27, 2021
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Spectrum Pharmaceuticals Presents Additional Twice Daily Dosing Data for Poziotinib at the AACR Virtual Meeting 2021
April 10, 2021
From Spectrum Pharmaceuticals
Via Business Wire
Tickers SPPI
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap